Clostridium difficile associated diseases - An emerging problem;Clostridium difficile-assoziierte diarrhö - Ein zunehmendes klinisches problem durch neue hochvirulente stämme

Krankenhaushygiene und Infektionsverhutung

Volumn 29, Issue 4, 2007, Pages 124-130

  Schneider, Thomas ^a   Eckmanns, Tim ^b   Ignatius, Ralf ^b   Weist, Klaus ^b   Liesenfeld, Oliver ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

Clostridium difficile associated diarrhea; Epidemiology; Hypervirulent strains; Prevention; Therapy

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; ENTEROTOXIN; METRONIDAZOLE; TOXIN; VANCOMYCIN;

ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM DETECTION; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASE; COLON RESECTION; COMBINATION CHEMOTHERAPY; ENDOSCOPY; GASTROINTESTINAL INFECTION; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; HYGIENE; INFECTION PREVENTION; MORBIDITY; MORTALITY;

EID: 34648821280     PISSN: 07203373     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.khinf.2007.06.011     Document Type: Article

References (25)

1. Ash, L., Baker, M.E., O'Malley Jr., C.M., et al., 2006. Colonic abnormalities on CT in adult hospitalized patients with Clostridium difficile colitis: prevalence and significance of findings. American Journal of Radiology 186, 1393-1400.
2. Babcock, G.J.M.R., Coccia, J.A., Esshaki, D.J., et al.: Human monoclonal antibody against toxin A protects hamsters from Clostridium difficile disease. Paper presented at the 42nd Annual Meeting of the Infectious Disease Society of America. Boston 2004; September 30-October 3, 2004.
3. Bartlett, J.G., Ondernok, A.B., Cisneros, R.L., Kasper, D.L., 1977. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 136, 701-705.
4. Bartlett, J.G., 2006. Narrative Review: The New Epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 145, 758-764.
5. Bricker, E., Garg, R., Nelson, R., et al., 2005. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev (1), CD004610.
6. Centers for Disease Control and Prevention (CDC): Severe Clostridium difficile-associated disease in populations previously at low risk-four states, 2005. MMWR Morb Mortal Wkly Rep. 2005 Dec 2;54(47):1201-5.
7. Cloud, J., Kelly, C.P., 2007. Update on Clostridium difficile associated disease. Curr Opin Gastroenterol 23, 4-9.
8. Fekety, R., 1997. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 92 (5), 739-750.
9. Fernandez, A., Anand, G., Friedenberg, F., 2004. Factors associated with failure of metronidazole in Clostridium difficile-associated disease. J Clin Gastroenterol 38 (5), 414-418.
10. Gerding, D.N., Johnson, S., Peterson, L.R., Mulligan, M.E., Silva, J. Jr.: Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol. 1995 Aug;16(8):459-77. Review.
11. Heimesaat, M.M., Granzow, K., Leidinger, H., Liesenfeld, O.: Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxin A in stool samples of patients with antibiotic-associated diarrhea. Infection. 2005 Oct;33(5-6):340-4.
12. Koss, K., Clark M, A., Sanders, D.S., et al., 2006. The outcome of surgery in fulminant Clostridium difficile colitis. Clorectal Dis 8, 149-154.
13. Kuijper, E.J., van den Berg, R.J., Debast, S., et al.: Clostridium difficile ribotype 027, toxinotype III, the Netherlands. Emerg Infect Dis 2006 May;12(5):827-30.
14. Kuijper, E.J., Coignard, B., Tull, P., 2006. the ESCMID Study Group for Clostridium difficile (ESGCD): Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect Oct;12 Suppl 6:2-18.
15. Kyne, L., Hamel, M.B., Polavaram, R., Kelly, C.P., 2002. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis Feb 1;34(3):346-53. Epub 2001 Dec 17.
16. Louie, T.J., Peppe, J., Watt, C.K., et al., 2006. Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment mild to moderately severe Clostridium difficile-associated diarrhea. Clin Infect Dis 43, 411-420.
17. McDonald, L.C., Killgore, G.E., Thompson, A., et al., 2005. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med Dec 8;353(23):2433-41. Epub 2005 Dec 1.
18. McDonald, L.C., Owings, M., Jernigan, D.B., 2006. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis. Mar;12(3):409-15.
19. McFarland, L.V., Mulligan, M.E., Kwok, R.Y., Stamm, W.E., 1989. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med Jan 26;320(4):204-10.
20. McFarland, L.V., Surawicz, C.M., Greenberg, R.N., et al., 1994. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. Jama 271 (24), 1913-1918.
21. Pepin, J., Valiquette, L., Alary, M.E., et al., 2004. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease seventy. Cmaj 171 (5), 466-472.
22. Schroder, O., Gerhard, R., Stein, J., 2006. Antibiotika-assoziierte Diarrhö [Antibiotic-associated diarrhea]. Z Gastroenterol Feb;44(2):193-204. Review. German.
23. Sebaihia, M., Wren, B.W., Mullany, P., et al., 2006. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet Jul;38(7):779-86. Epub 2006 Jun 25.
24. Suarawicz, C.M., 2004. Treatment of recurrent Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol & Hepatol 1, 32-38.
25. Tedesco, F.J., Barton, R.W., Alpers, D.H., Clindamycin-associated colitis. A prospective study. Ann Intern Med 1974;Oct;81(4):429-33.